These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12752623)

  • 21. [Digital full field mammography: comparison between radiographic direct magnification and digital monitor zooming].
    Fischer U; Baum F; Obenauer S; Funke M; Hermann KP; Grabbe E
    Radiologe; 2002 Apr; 42(4):261-4. PubMed ID: 12063732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease.
    Tse NY; Hoh CK; Hawkins RA; Zinner MJ; Dahlbom M; Choi Y; Maddahi J; Brunicardi FC; Phelps ME; Glaspy JA
    Ann Surg; 1992 Jul; 216(1):27-34. PubMed ID: 1632699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of cancers not diagnosed at stereotactic core breast biopsy.
    Liberman L; Dershaw DD; Glassman JR; Abramson AF; Morris EA; LaTrenta LR; Rosen PP
    Radiology; 1997 Apr; 203(1):151-7. PubMed ID: 9122384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years.
    Allen SD; Osin P; Nerurkar A
    Eur J Surg Oncol; 2014 Jul; 40(7):824-9. PubMed ID: 24742589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.
    Wahl RL; Cody RL; Hutchins GD; Mudgett EE
    Radiology; 1991 Jun; 179(3):765-70. PubMed ID: 2027989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
    Hogan MP; Goldman DA; Dashevsky B; Riedl CC; Gönen M; Osborne JR; Jochelson M; Hudis C; Morrow M; Ulaner GA
    J Nucl Med; 2015 Nov; 56(11):1674-80. PubMed ID: 26294295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contrast-enhanced digital mammography: initial clinical experience.
    Jong RA; Yaffe MJ; Skarpathiotakis M; Shumak RS; Danjoux NM; Gunesekara A; Plewes DB
    Radiology; 2003 Sep; 228(3):842-50. PubMed ID: 12881585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical roles of breast 3T MRI, FDG PET/CT, and breast ultrasound for asymptomatic women with an abnormal screening mammogram.
    Chou CP; Peng NJ; Chang TH; Yang TL; Hu C; Lin HS; Huang JS; Pan HB
    J Chin Med Assoc; 2015 Dec; 78(12):719-25. PubMed ID: 26364959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast biopsy for mammographically detected nonpalpable lesions using a vacuum-assisted biopsy device (Mammotome) and upright-type stereotactic mammography unit without a digital imaging system: experience of 500 biopsies.
    Ohsumi S; Taira N; Takabatake D; Takashima S; Hara F; Takahashi M; Kiyoto S; Aogi K; Nishimura R
    Breast Cancer; 2014 Mar; 21(2):123-7. PubMed ID: 22477266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An amorphous selenium based positron emission mammography camera with avalanche gain.
    Reznik A; Lui BJ; Rowlands JA
    Technol Cancer Res Treat; 2005 Feb; 4(1):61-7. PubMed ID: 15649089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of multi-focal breast carcinoma using 2[18F] fluoro-deoxy-D-glucose positron emission tomography (FDG-PET)].
    Scharl A; Scheidhauer K; Pietrzyk U; Göhring UJ; Schomäcker K
    Geburtshilfe Frauenheilkd; 1996 Aug; 56(8):434-7. PubMed ID: 8974899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.
    Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C
    J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [40 years of progress in breast imaging].
    De Maulmont C; Cherel P; Ouhioun O; Becette V; Stevens D; Plantet MM; Hagay C
    Pathol Biol (Paris); 2000 Nov; 48(9):801-11. PubMed ID: 11141915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study.
    Fajardo LL; Pisano ED; Caudry DJ; Gatsonis CA; Berg WA; Connolly J; Schnitt S; Page DL; McNeil BJ;
    Acad Radiol; 2004 Mar; 11(3):293-308. PubMed ID: 15035520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
    Avril N; Dose J; Jänicke F; Ziegler S; Römer W; Weber W; Herz M; Nathrath W; Graeff H; Schwaiger M
    J Natl Cancer Inst; 1996 Sep; 88(17):1204-9. PubMed ID: 8780629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial experience of integrated PET/MR mammography in patients with invasive ductal carcinoma.
    Kong EJ; Chun KA; Bom HS; Lee J; Lee SJ; Cho IH
    Hell J Nucl Med; 2014; 17(3):171-6. PubMed ID: 25397622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous removal of malignant mammographic lesions at stereotactic vacuum-assisted biopsy.
    Liberman L; Dershaw DD; Rosen PP; Morris EA; Abramson AF; Borgen PI
    Radiology; 1998 Mar; 206(3):711-5. PubMed ID: 9494489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereotactic brain biopsy guided by positron emission tomography (PET) with [F-18]fluorodeoxyglucose and [C-11]methionine.
    Pirotte B; Goldman S; David P; Wikler D; Damhaut P; Vandesteene A; Salmon L; Brotchi J; Levivier M
    Acta Neurochir Suppl; 1997; 68():133-8. PubMed ID: 9233429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effectiveness of positron emission mammography and MRI in the contralateral breast of women with newly diagnosed breast cancer.
    Berg WA; Madsen KS; Schilling K; Tartar M; Pisano ED; Larsen LH; Narayanan D; Kalinyak JE
    AJR Am J Roentgenol; 2012 Jan; 198(1):219-32. PubMed ID: 22194501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.